The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Abstract
The aim of this work was to investigate the mechanistic evaluation of physicochemical properties of new engineered lactose on aerosolisation performance of salbutamol sulphate (SS) delivered from dry powder inhaler (DPI). Different crystallised lactose particles were obtained from binary mixtures of butanol:acetone. The sieved fractions (63-90 μm) of crystallised lactose were characterised in terms of size, shape, flowability, true density and aerosolisation performance (using multiple twin stage impinger (MSLI), Aerolizer(®) inhaler device, and salbutamol sulphate as a model drug). Compared to commercial lactose, crystallised lactose particles were less elongated, covered with fine lactose particles, and had a rougher surface morphology. The crystallised lactose powders had a considerably lower bulk and tap density and poorer flow when compared to commercial lactose. Engineered carrier with better flow showed improved drug content homogeneity, reduced amounts of drug "deposited" on the inhaler device and throat, and a smaller drug aerodynamic diameter upon inhalation. Aerodynamic diameter of salbutamol sulphate increased as lactose aerodynamic diameter decreased (linear, R(2)=0.9191) and/or as fine particle lactose content increased (linear, R(2)=0.8653). Improved drug aerosolisation performance in the case of crystallised lactose particles was attributed to lower drug-carrier adhesion forces due to a rougher surface and higher fine particle content. In conclusion, this work proved that using binary combinations of solvents in crystallisation medium is vital in modification of the physicochemical and micromeritic properties of carriers to achieve a desirable aerosolisation performance from DPI formulations. Among all lactose samples, lactose particles crystallised from pure butanol generated the highest overall DPI formulations desirability.Citation
Kaialy, W. et al. (2012) The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers, Colloids and Surfaces B: Biointerfaces, 89, pp. 29-39Publisher
ElsevierJournal
Colloids and surfaces. B, BiointerfacesPubMed ID
21962946Type
Journal articleLanguage
enDescription
This is a metadata record only. The full text of the article is not available in this repository.ISSN
1873-4367ae974a485f413a2113503eed53cd6c53
10.1016/j.colsurfb.2011.08.019
Scopus Count
Collections
Related articles
- Effect of carrier particle shape on dry powder inhaler performance.
- Authors: Kaialy W, Alhalaweh A, Velaga SP, Nokhodchi A
- Issue date: 2011 Dec 12
- Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
- Authors: Kaialy W, Ticehurst M, Nokhodchi A
- Issue date: 2012 Feb 28
- The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
- Authors: Kaialy W, Martin GP, Ticehurst MD, Momin MN, Nokhodchi A
- Issue date: 2010 Jun 15
- Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
- Authors: Zeng XM, MacRitchie HB, Marriott C, Martin GP
- Issue date: 2007 Mar 21
- Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.
- Authors: Kaialy W, Momin MN, Ticehurst MD, Murphy J, Nokhodchi A
- Issue date: 2010 Sep 1